Cabaletta Bio Inc
CABA
NASDAQ
Biotechnology
$2.75
USD
+0.04 (+1.48%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $442.69M
Volume 2.3M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc | $518.86M | - | +1199.6% | - | |
PROK | Prokidney Corp | $510.48M | - | +190.5% | - | |
KYTX | Kyverna Therapeutics Inc | $479.67M | - | - | - | |
BNTC | Benitec Biopharma Inc | $473.06M | - | - | - | |
QTTB | Q32 Bio Inc | $468.57M | 15.71 | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - | |
CABA | Cabaletta Bio Inc | $451.25M | - | - | - | |
RZLT | Rezolute Inc | $450.65M | - | - | - | |
EDIT | Editas Medicine Inc | $441.54M | - | +20.8% | - |
Top Peer by Growth
Q32 Bio Inc
+81.9% YoY Revenue
Lowest P/E Ratio
Q32 Bio Inc
15.71x P/E
Best 1-Year Return
Q32 Bio Inc
+749.2% Return